Business Description
TherapeuticsMD Inc
NAICS : 325412
SIC : 2834
ISIN : US88338N1072
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.69 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -1.63 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -32.41 | |||||
Beneish M-Score | 174.64 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -78 | |||||
3-Year EBITDA Growth Rate | 70.3 | |||||
3-Year EPS without NRI Growth Rate | 71.9 | |||||
3-Year FCF Growth Rate | 57.7 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 88.75 | |||||
9-Day RSI | 73.19 | |||||
14-Day RSI | 62.91 | |||||
6-1 Month Momentum % | -19.31 | |||||
12-1 Month Momentum % | -54.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.03 | |||||
Quick Ratio | 2.03 | |||||
Cash Ratio | 0.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.4 | |||||
Shareholder Yield % | 118.38 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -572.79 | |||||
Net Margin % | -610.94 | |||||
FCF Margin % | -989.84 | |||||
ROE % | -21 | |||||
ROA % | -13.25 | |||||
ROIC % | -15.37 | |||||
ROC (Joel Greenblatt) % | -83.55 | |||||
ROCE % | -15.82 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 20.34 | |||||
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.94 | |||||
EV-to-EBIT | -4.11 | |||||
EV-to-EBITDA | -5.07 | |||||
EV-to-Revenue | 23.75 | |||||
EV-to-Forward-Revenue | 0.93 | |||||
EV-to-FCF | -2.33 | |||||
Earnings Yield (Greenblatt) % | -24.3 | |||||
FCF Yield % | -45.81 | |||||
Forward Rate of Return (Yacktman) % | 24913.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TherapeuticsMD Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.915 | ||
EPS (TTM) (€) | -0.494 | ||
Beta | -0.19 | ||
Volatility % | 57.64 | ||
14-Day RSI | 62.91 | ||
14-Day ATR (€) | 0.046894 | ||
20-Day SMA (€) | 1.5055 | ||
12-1 Month Momentum % | -54.47 | ||
52-Week Range (€) | 1.34 - 3.64 | ||
Shares Outstanding (Mil) | 11.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TherapeuticsMD Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TherapeuticsMD Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
TherapeuticsMD Inc Frequently Asked Questions
What is TherapeuticsMD Inc(STU:29TA)'s stock price today?
When is next earnings date of TherapeuticsMD Inc(STU:29TA)?
Does TherapeuticsMD Inc(STU:29TA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |